Answers are grounded in this paper and cite their sources.
Intestinal mobility disorders are either hypo or hypermotility conditions that affect the gastrointestinal tract due to smooth muscle or neuronal disorders. Betalains are good candidates to be evaluated for their intestinal modulating properties since they may have a higher safety index and pleiotropic efficacy. In this small sample, clinical trials (N = 26 cases of motility disorders), fasting, and betalains intake cases of motility disorders had been measured for their electro enterography EEn
No takes yet. Share an insight, caveat, or question.
Majeed et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: